Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases

Explore clinical trials studying Autoimmune Diseases. Study availability and eligibility vary by location and protocol.

614 public trials 169 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases trial results

Completed

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

NCT00419419

Conditions
Autoimmune Diseases, Cardiovascular Diseases, Connective Tissue Diseases, +14 more
Locations
  • Standford Medical School Stanford, California, United States
  • University of Connecticut Farmington, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Lab Study of MQX-503 in Treatment of Raynaud's

NCT00253331

Conditions
Autoimmune Diseases, Cardiovascular Diseases, Connective Tissue Diseases, +13 more
Locations
  • Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
  • University of Washington Medical College Seattle, Washington, United States
View Trial Details
Completed

Rituximab in the Treatment of Graves' Disease

NCT00150111

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark
  • Department of Hematology, Odense University Hospital Odense, Denmark
View Trial Details
Completed

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

NCT00035308

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Rheumatology Associates of North Alabama Huntsville, Alabama, United States
  • Montgomery Rheumatology Associates Montgomery, Alabama, United States
  • Arizona Arthritis & Rheumatology Paradise Valley, Arizona, United States
View all 82 locations
View Trial Details
Terminated

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT06342960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Charite- Universitätsklinikum Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details

Related conditions